Table 1.

Statistical analysis of ANGPTL4 mRNA with clinical factors of HCC patients using two-tailed T-test

		ANGPTL4mRNA in HCC patients
		Tumor/non-tumor difference		Tumor		Non-tumor
Clinical factors	Number (n)	Mean (Log2)	P	Mean (Log2)	p	Mean (Log2)	p
Sex
Male	88	−1.20	0.889	5.85	0.381	7.15	0.670
Female	22	−1.12		6.32		7.02
Venous infiltration
Absent	51	−0.67	0.023*	6.51	0.012*	7.18	0.692
Present	59	−1.63		5.45		7.08
Differentiation a
Moderately or well	87	−0.82	0.000***	6.21	0.013*	7.17	0.639
Undifferentiated or poorly	18	−3.21		4.80		7.01
pTNM staging a
Early stage	34	−0.35	0.007**	6.67	0.025*	7.04	0.646
Advanced stage	75	−1.56		5.66		7.16
Cirrhosis a
No cirrhosis	39	−0.97	0.479	5.98	0.981	6.98	0.382
Cirrhosis	69	−1.29		5.97		7.20
Recurrence
No recurrence	49	−0.69	0.035*	6.58	0.006**	7.20	0.577
Recurrence	61	−1.58		5.43		7.07
Hepatitis B surface antigen
Negative	16	−0.99	0.700	5.53	0.429	6.61	0.080
Positive	94	−1.22		6.01		7.22

^aTotal number less than 110 due to missing data; *, p<0.05; **, p<0.01; ***, p<0.001.